Medicenna Therapeutics to join two investor conferences in February 2025

financialpost.com February 5, 2025, 01:01 PM UTC

Medicenna Therapeutics will participate in two investor conferences in February 2025. The events will include a presentation on February 11 and a fireside chat on February 28 in New York City. The company will also hold one-on-one meetings with investors during these conferences. Medicenna focuses on developing Superkines for cancer and autoimmune diseases, with ongoing clinical trials for its therapies.


With a significance score of 1.6, this news ranks in the top 72% of today's 17788 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 8000 minimalists.